EP3820874
Sértækir estrógenviðtakasundrarar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.7.2019EP published:
30.11.2022EP application number:
19746252.6
EP translation filed:
9.1.2023Grant published:
15.2.2023EPO information:
European Patent Register
Max expiry date:
10.7.2039Expiry date:
10.7.2026Next due date:
31.7.2026
Title in English:
SELECTIVE ESTROGEN RECEPTOR DEGRADERSLanguage of the patent:
English
Timeline
Today
11.7.2019EP application
30.11.2022EP Publication
9.1.2023Translation submitted
15.2.2023Registration published
10.7.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
COHEN, Jeffrey DanielAddress:
Indianapolis, Indiana 46206-6288, US
Name:
SALL, Daniel JonAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862697100 PDate:
12.7.2018Country:
US
Number:
201962825172 PDate:
28.3.2019Country:
US
Classification
Categories:
C07D 491/052, A61K 31/436, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.6.2023
Expires: 10.7.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 19.6.2024
Expires: 10.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.7.2025
Expires: 10.7.2026
Payer: Árnason Faktor ehf.